Terms: = Lung cancer AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575 AND Treatment
33 results:
1. First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations.
Blasi M; Kuon J; Lüders H; Misch D; Kauffmann-Guerrero D; Hilbrandt M; Kazdal D; Falkenstern-Ge RF; Hackanson B; Dintner S; Faehling M; Kirchner M; Volckmar AL; Kopp HG; Allgäuer M; Grohé C; Tufman A; Reck M; Frost N; Stenzinger A; Thomas M; Christopoulos P
Eur J Cancer; 2024 Mar; 199():113556. PubMed ID: 38271745
[TBL] [Abstract] [Full Text] [Related]
2. Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer.
Zu L; He J; Zhou N; Tang Q; Liang M; Xu S
Cell Death Dis; 2023 Dec; 14(12):798. PubMed ID: 38057344
[TBL] [Abstract] [Full Text] [Related]
3. Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts.
Zhang L; Wang Y; Wang L; Wang M; Li S; He J; Ji J; Li K; Cao L
J Mol Med (Berl); 2024 Jan; 102(1):69-79. PubMed ID: 37978056
[TBL] [Abstract] [Full Text] [Related]
4. Single-center phase 2 study of PD-1 inhibitor combined with DNA hypomethylation agent + CAG regimen in patients with relapsed/refractory acute myeloid leukemia.
Gao XN; Su YF; Li MY; Jing Y; Wang J; Xu L; Zhang LL; Wang A; Wang YZ; Zheng X; Li YF; Liu DH
Cancer Immunol Immunother; 2023 Aug; 72(8):2769-2782. PubMed ID: 37166484
[TBL] [Abstract] [Full Text] [Related]
5. Allogeneic cord blood regulatory T cells can resolve lung inflammation.
Lyu MA; Huang M; Zeng K; Li L; Khoury JD; Nishimoto M; Ma H; Sadeghi T; Mukherjee S; Slutsky AS; Flowers CR; Parmar S
Cytotherapy; 2023 Mar; 25(3):245-253. PubMed ID: 36437190
[TBL] [Abstract] [Full Text] [Related]
6. Correlation between the Treg/Thl7 Index and the Efficacy of PD-1 Monoclonal Antibody in Patients with Advanced Non-Small-Cell lung cancer Complicated with Chronic Obstructive Pulmonary Disease.
Wang X; She X; Gao W; Liu X; Shi B
Comput Math Methods Med; 2022; 2022():2923998. PubMed ID: 35915772
[TBL] [Abstract] [Full Text] [Related]
7. Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell lung cancer (NSCLC).
Agulnik JS; Papadakis AI; Pepe C; Sakr L; Small D; Wang H; Kasymjanova G; Spatz A; Cohen V
Curr Oncol; 2022 Feb; 29(2):1107-1116. PubMed ID: 35200593
[TBL] [Abstract] [Full Text] [Related]
8. Tumor-infiltrating lymphocytes are functionally inactivated by CD90+ stromal cells and reactivated by combined Ibrutinib and Rapamycin in human pleural mesothelioma.
Yang H; Berezowska S; Dorn P; Zens P; Chen P; Peng RW; Marti TM; Kocher GJ; Schmid RA; Hall SRR
Theranostics; 2022; 12(1):167-185. PubMed ID: 34987640
[No Abstract] [Full Text] [Related]
9. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in lung Adenocarcinoma.
Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
Front Immunol; 2021; 12():693062. PubMed ID: 34497605
[TBL] [Abstract] [Full Text] [Related]
10. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
Gao L; Zhang L
BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
[TBL] [Abstract] [Full Text] [Related]
11. Circulating regulatory T cells predict efficacy and atypical responses in lung cancer patients treated with PD-1/PD-L1 inhibitors.
Kang DH; Chung C; Sun P; Lee DH; Lee SI; Park D; Koh JS; Kim Y; Yi HS; Lee JE
Cancer Immunol Immunother; 2022 Mar; 71(3):579-588. PubMed ID: 34278517
[TBL] [Abstract] [Full Text] [Related]
12. Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patient.
Zhong R; Zhang Y; Chen D; Cao S; Han B; Zhong H
Cancer Immunol Immunother; 2021 Aug; 70(8):2261-2274. PubMed ID: 33506299
[TBL] [Abstract] [Full Text] [Related]
13. Anti-inflammatory effects of α-MSH through p-CREB expression in sarcoidosis like granuloma model.
Zhang C; Chery S; Lazerson A; Altman NH; Jackson R; Holt G; Campos M; Schally AV; Mirsaeidi M
Sci Rep; 2020 Apr; 10(1):7277. PubMed ID: 32350353
[TBL] [Abstract] [Full Text] [Related]
14. Interleukin-7 Resensitizes Non-Small-Cell lung cancer to Cisplatin via Inhibition of ABCG2.
Ke B; Wei T; Huang Y; Gong Y; Wu G; Liu J; Chen X; Shi L
Mediators Inflamm; 2019; 2019():7241418. PubMed ID: 31915416
[TBL] [Abstract] [Full Text] [Related]
15. IL-7-Mediated IL-7R-JAK3/STAT5 signalling pathway contributes to chemotherapeutic sensitivity in non-small-cell lung cancer.
Shi L; Xu Z; Yang Q; Huang Y; Gong Y; Wang F; Ke B
Cell Prolif; 2019 Nov; 52(6):e12699. PubMed ID: 31599032
[TBL] [Abstract] [Full Text] [Related]
16. Stereotactic Ablative Radiation Therapy for Pulmonary Recurrence-Based Oligometastatic Non-Small Cell lung cancer: Survival and Prognostic Value of Regulatory T Cells.
Liu C; Sun B; Hu X; Zhang Y; Wang Q; Yue J; Yu J
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1055-1064. PubMed ID: 31437470
[TBL] [Abstract] [Full Text] [Related]
17. Yi-qi-yang-yin-tian-sui-fang enhances cisplatin-induced tumor eradication and inhibits interleukin-7 reduction in non-small cell lung cancer.
Ke B; Wu X; Yang Q; Huang Y; Wang F; Gong Y; Liu J; Shi L
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138762
[TBL] [Abstract] [Full Text] [Related]
18. The detection and clinical significance of peripheral regulatory CD4
Qiu J; Che G; Liu F; Sha X; Ju S; Ma H; Feng L
Clin Transl Oncol; 2019 Oct; 21(10):1343-1347. PubMed ID: 30788838
[TBL] [Abstract] [Full Text] [Related]
19. A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance.
Wang W; Song Z; Zhang Y
Cancer Med; 2017 Jan; 6(1):154-162. PubMed ID: 28000387
[TBL] [Abstract] [Full Text] [Related]
20. Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment.
Kordasti S; Costantini B; Seidl T; Perez Abellan P; Martinez Llordella M; McLornan D; Diggins KE; Kulasekararaj A; Benfatto C; Feng X; Smith A; Mian SA; Melchiotti R; de Rinaldis E; Ellis R; Petrov N; Povoleri GA; Chung SS; Thomas NS; Farzaneh F; Irish JM; Heck S; Young NS; Marsh JC; Mufti GJ
Blood; 2016 Sep; 128(9):1193-205. PubMed ID: 27281795
[TBL] [Abstract] [Full Text] [Related]
[Next]